In the present study, we demonstrated that Trim21 is crucial for regulating OB-mediated bone formation and OC-mediated bone resorption, thereby providing a basis for exploring Trim21 as a novel dual-targeting approach for treating pathological skeletal diseases, including osteoporosis. Here, TRIM21 is linked to bone disorder.